G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan · Delayed Price · Currency is TWD 41.35
+0.05 (0.12%)
Jan 21, 2026, 1:20 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 2.63 billion as of January 21, 2026. Its market cap has decreased by -22.87% in one year.
Market Cap
2.63B
Enterprise Value
2.22B
Revenue
311.78M
Ranking
n/a
PE Ratio
18.45
Stock Price
41.35
Market Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has increased from 2.62B to 2.63B, an increase of 0.60%. That is a compound annual growth rate of 0.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.63B | -3.61% |
| Dec 31, 2025 | 2.73B | -18.14% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.65B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.72B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |